Unknown

Dataset Information

0

Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction.


ABSTRACT: The overall effect of brain zinc (Zn(2+)) in the progression and development of Alzheimer's disease (AD) is still not completely understood. Although an excess of Zn(2+) can exacerbate the pathological features of AD, a deficit of Zn(2+) intake has also been shown to increase the volume of amyloid plaques in AD transgenic mice. In this study, we investigated the effect of dietary Zn(2+) supplementation (30 p.p.m.) in a transgenic mouse model of AD, the 3xTg-AD, that expresses both ? amyloid (A?)- and tau-dependent pathology. We found that Zn(2+) supplementation greatly delays hippocampal-dependent memory deficits and strongly reduces both A? and tau pathology in the hippocampus. We also evaluated signs of mitochondrial dysfunction and found that Zn(2+) supplementation prevents the age-dependent respiratory deficits we observed in untreated 3xTg-AD mice. Finally, we found that Zn(2+) supplementation greatly increases the levels of brain-derived neurotrophic factor (BDNF) of treated 3xTg-AD mice. In summary, our data support the idea that controlling the brain Zn(2+) homeostasis may be beneficial in the treatment of AD.

SUBMITTER: Corona C 

PROVIDER: S-EPMC3035902 | biostudies-other | 2010

REPOSITORIES: biostudies-other

altmetric image

Publications

Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction.

Corona C C   Masciopinto F F   Silvestri E E   Viscovo A Del AD   Lattanzio R R   Sorda R La RL   Ciavardelli D D   Goglia F F   Piantelli M M   Canzoniero L M T LM   Sensi S L SL  

Cell death & disease 20101028


The overall effect of brain zinc (Zn(2+)) in the progression and development of Alzheimer's disease (AD) is still not completely understood. Although an excess of Zn(2+) can exacerbate the pathological features of AD, a deficit of Zn(2+) intake has also been shown to increase the volume of amyloid plaques in AD transgenic mice. In this study, we investigated the effect of dietary Zn(2+) supplementation (30 p.p.m.) in a transgenic mouse model of AD, the 3xTg-AD, that expresses both β amyloid (Aβ)  ...[more]

Similar Datasets

| S-EPMC3044176 | biostudies-literature
| S-EPMC8019944 | biostudies-literature
| S-EPMC9372289 | biostudies-literature
| S-EPMC4648633 | biostudies-literature
| S-EPMC8563005 | biostudies-literature
| S-EPMC10044705 | biostudies-literature
| S-EPMC8359155 | biostudies-literature
| S-EPMC3948211 | biostudies-literature
| S-EPMC9131098 | biostudies-literature
| S-EPMC5099116 | biostudies-literature